Related references
Note: Only part of the references are listed.Immune Regulation of Human Herpesviruses and Its Implications for Human Transplantation
C. Smith et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
The human JC polyomavirus (JCPyV): virological background and clinical implications
Hans H. Hirsch et al.
APMIS (2013)
Mortality Rates of Human Metapneumovirus and Respiratory Syncytial Virus Lower Respiratory Tract Infections in Hematopoietic Cell Transplantation Recipients
Christian Renaud et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
BK Viremia Precedes Hemorrhagic Cystitis in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Benjamin L. Laskin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Outcome of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Hematopoietic Cell Transplant Recipients Receiving Aerosolized Ribavirin: Significance of Stem Cell Source and Oxygen Requirement
Sachiko Seo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation
Ulrike Gerdemann et al.
BLOOD (2013)
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
Emily Blyth et al.
BLOOD (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit
N. Lehners et al.
BONE MARROW TRANSPLANTATION (2013)
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT
J. Rahiala et al.
BONE MARROW TRANSPLANTATION (2013)
Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation
J. Casey et al.
BONE MARROW TRANSPLANTATION (2013)
Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
Hans H. Hirsch et al.
CLINICAL INFECTIOUS DISEASES (2013)
Rare and Emerging Viral Infections in Transplant Recipients
Jesse J. Waggoner et al.
CLINICAL INFECTIOUS DISEASES (2013)
Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use
Sarah J. Albon et al.
CYTOTHERAPY (2013)
Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
Vanya Icheva et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: Treatment response and evidence for nosocomial transmission
Minna Koskenvuo et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Respiratory Viral Infections after Hematopoietic Stem Cell Transplantation in Children
Jae Hong Choi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
Severe metapneumovirus infections among immunocompetent and immunocompromised patients admitted to hospital with respiratory infection
Juliana Sinohara Souza et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2013)
Detection of Respiratory Viruses in Asymptomatic Children Undergoing Allogeneic Hematopoietic Cell Transplantation
Ashok Srinivasan et al.
PEDIATRIC BLOOD & CANCER (2013)
The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy
Mindy S. Lo et al.
PEDIATRIC TRANSPLANTATION (2013)
Early Human Herpesvirus Type 6 Reactivation after Allogeneic Stem Cell Transplantation: A Large-Scale Clinical Study
Remy Dulery et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Michael Uhlin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Use of TK-cells in haploidentical hematopoietic stem cell transplantation
Giacomo Oliveira et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Natalia Lapteva et al.
CYTOTHERAPY (2012)
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant
Uluhan Sili et al.
CYTOTHERAPY (2012)
Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment
Jianjian Jin et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2012)
Selective T-Cell Depletion for Haplotype-Mismatched Allogeneic Stem Cell Transplantation
Jean-Philippe Bastien et al.
SEMINARS IN ONCOLOGY (2012)
WU and KI Polyomaviruses in Respiratory Samples from Allogeneic Hematopoietic Cell Transplant Recipients
Jane Kuypers et al.
EMERGING INFECTIOUS DISEASES (2012)
Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies
Stephan Mielke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary?
Brian C. Betts et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient
A. Balduzzi et al.
BONE MARROW TRANSPLANTATION (2011)
Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
Karl S. Peggs et al.
CLINICAL INFECTIOUS DISEASES (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
Anita Schmitt et al.
TRANSFUSION (2011)
Optimization Manufacture of Virus- and Tumor-Specific T Cells
Natalia Lapteva et al.
STEM CELLS INTERNATIONAL (2011)
Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy
Sujith Samarasinghe et al.
BLOOD (2010)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease
Jean-Philippe Bastien et al.
BLOOD (2010)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
J. Joseph Melenhorst et al.
BLOOD (2010)
How I treat adenovirus in hematopoietic stem cell transplant recipients
Caroline A. Lindemans et al.
BLOOD (2010)
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
Andreas Moosmann et al.
BLOOD (2010)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Tobias Feuchtinger et al.
BLOOD (2010)
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
Michael Uhlin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)
Juan F. Vera et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Hematopoietic Cell Transplantation and Emerging Viral Infections
D. Chatzidimitriou et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Ann M. Leen et al.
BLOOD (2009)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Patrick J. Hanley et al.
BLOOD (2009)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Fabio Ciceri et al.
LANCET ONCOLOGY (2009)
Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2009)
Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation
N. Khanna et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity
Udo F. Hariwig et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome
P. J. Anne de Pagter et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
Stephan Mielke et al.
BLOOD (2008)
Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation
Kenneth P. Micklethwaite et al.
BLOOD (2008)
Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies
Jeff K. Davies et al.
BLOOD (2008)
Cellular immune responses to BK virus
Patrizia Comoli et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2008)
Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: An altered immune response?
Patricia Mercier-Letondal et al.
HUMAN GENE THERAPY (2008)
Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation
P. J. de Pagter et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Incidence of HHV7 in donors and recipients of allogeneic hematopoietic stem cell transplantation
Petr Hubacek et al.
PEDIATRIC BLOOD & CANCER (2008)
Selective Depletion of Alloreactive T Lymphocytes Using Patient-Derived Nonhematopoietic Stimulator Cells in Allograft Engineering
Marion Nonn et al.
TRANSPLANTATION (2008)
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy
Ann M. Leen et al.
JOURNAL OF VIROLOGY (2008)
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease
P. Norja et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection
Angela J. Peck et al.
BLOOD (2007)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation
Siok-Keen Tey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
The suicide gene therapy challenge: How to improve a successful gene therapy approach
Chiara Bonini et al.
MOLECULAR THERAPY (2007)
In vitro methotrexate as a practical approach to selective allodepletion
Atul Sathe et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation
G. D. Myers et al.
BONE MARROW TRANSPLANTATION (2007)
Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation
Kenneth Micklethwaite et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
P. Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation
Fabio Ciceri et al.
BLOOD (2007)
Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders
M. K. Gandhi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens
Julia Neudorfer et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
Thomas C. Wehler et al.
BLOOD (2007)
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies
Catia Traversari et al.
BLOOD (2007)
Community respiratory virus infections in immunocompromised patients: Hematopoletic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection
Yae-Jean Kim et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Persis J. Amrolia et al.
BLOOD (2006)
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
T Feuchtinger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Parvovirus B19 infection after transplantation: A review of 98 cases
Albert J. Eid et al.
CLINICAL INFECTIOUS DISEASES (2006)
Polyomavirus-associated nephropathy: update on BK virus-specific immunity
P. Comoli et al.
TRANSPLANT INFECTIOUS DISEASE (2006)
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation
C Berger et al.
BLOOD (2006)
Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes
UF Hartwig et al.
BONE MARROW TRANSPLANTATION (2006)
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
K Perruccio et al.
BLOOD (2005)
Emerging viral infections after hematopoietic cell transplantation
M Boeckh et al.
PEDIATRIC TRANSPLANTATION (2005)
Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)
GD Myers et al.
BONE MARROW TRANSPLANTATION (2005)
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation
SR Solomon et al.
BLOOD (2005)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation
DM Zerr et al.
CLINICAL INFECTIOUS DISEASES (2005)
Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications
AM Leen et al.
BLOOD (2004)
Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation
A Plentz et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Severe multiorgan failure after parvovirus B19 infection in an allogeneic stem cell transplant recipient
HJ Klümpen et al.
BONE MARROW TRANSPLANTATION (2004)
Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells
AM Leen et al.
BLOOD (2004)
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines
KS Peggs et al.
LANCET (2003)
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukernic responses
PJ Amrolia et al.
BLOOD (2003)
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies
M Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Safety of retroviral gene marking with a truncated NGF receptor
C Bonini et al.
NATURE MEDICINE (2003)
Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes:: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation
SR Solomon et al.
CYTOTHERAPY (2002)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells
M Guimond et al.
BLOOD (2002)
Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation:: a phase 1/2 study
I André-Schmutz et al.
LANCET (2002)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process
BJ Chen et al.
BLOOD (2002)
Donor lymphocyte infusion therapy
KS Roush et al.
TRANSFUSION MEDICINE REVIEWS (2002)
Infusion of autologous Epstein-Barr virus (EBV) -: specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
P Comoli et al.
BLOOD (2002)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
Parainfluenza virus 3 infection after stem cell transplant: Relevance to outcome of rapid diagnosis and ribavirin treatment
J Elizaga et al.
CLINICAL INFECTIOUS DISEASES (2001)
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft
P Tiberghien et al.
BLOOD (2001)
Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69)
B Fehse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
